‘news’
CD40 expression correlates with response to immunotherapy in melanoma patients
Mar. 1, 2022—By Wendy Bindeman Ann Richmond, professor of pharmacology, and Chi Yan, a research assistant professor in the Richmond lab, recently published a study showing that expression of a protein called CD40 can be used to predict response to immunotherapy in malignant melanoma. Their work was published in November 2021 in the journal Molecular Cancer. We...
Jenkins named Basic Sciences diversity, equity, and inclusion program manager
Sep. 16, 2021—By Wendy Bindeman The Vanderbilt University School of Medicine Basic Sciences recently welcomed Felysha Jenkins as its first Diversity, Equity, and Inclusion program manager. Basic Sciences is committed to fostering a diverse, inclusive environment that welcomes and supports trainees, faculty, and staff from all backgrounds. Throughout their long careers at Vanderbilt, Linda Sealy, formerly the...
Discovery of a pathway that regulates heart muscle regeneration
Sep. 9, 2021—Research led by Dylan Burnette, associate professor of cell and developmental biology, and first-author Abigail Neininger, a graduate student in the Burnette lab, identified the Hippo pathway as a key regulator of heart muscle cell division, which has large translational implications for treatments after a heart attack. Their article was published on September 7 in...
Donation of Awards and Scrapbooks Will Lead to New Understanding of the Life and Work of Nobel Laureate Dr. Earl Sutherland
Sep. 9, 2021—By Aaron Conley In late August of this year, Dr. Bill Sutherland visited the Vanderbilt University School of Medicine Basic Sciences dean, Larry Marnett, and Dr. Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics, to donate materials from the life of his father, Nobel laureate Dr. Earl Sutherland. The donated...
Scott Hiebert to serve as acting chair for the National Cancer Advisory Board
Sep. 28, 2020—By Lorena Infante Lara Scott Hiebert, Hortense B. Ingram Chair in Cancer Research and professor of biochemistry, will serve as acting chair for the National Cancer Advisory Board. Originally appointed by President Barack Obama in 2016, Hiebert will serve as a member of the board until his term ends in 2022. The NCAB comprises 18...